EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities

Marta Maccari, Chooyoung Baek, Mario Caccese, Susanna Mandruzzato, Alba Fiorentino, Valeria Internò, Alberto Bosio, Giulia Cerretti, Marta Padovan, Ahmed Idbaih iD, Giuseppe Lombardi iD

The Oncologist · 2024

DOI: 10.1093/oncolo/oyad321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, 2024. Verfasst von Marta Maccari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor. Standard therapies, including surgical resection, chemoradiation, and tumor treating fields, have not resulted in major improvements in the survival outcomes of patients with GBM. The lack of effective strategies has led to an increasing interest in immunotherapic approaches, considering the success in other solid tumors. However, GBM is a highly immunosuppressive tumor, as documented by the presence of several mechanisms of immune escape, which may represent a reason why immunotherapy clinical trials failed in this kind of tumor. In this review, we examine the current landscape of immunotherapy strategies in GBM, focusing on the challenge of immunoresistance and potential mechanisms to overcome it. We discussed completed and ongoing clinical trials involving immune checkpoint inhibitors, oncolytic viruses, vaccines, and CAR T-cell therapies, to provide insights into the efficacy and outcomes of different immunotherapeutic interventions. We also explore the impact of radiotherapy on the immune system within the GBM microenvironment highlighting the complex interactions between radiation treatment and the immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansImmunotherapyImmunotherapy, AdoptiveTumor Microenvironment

Stichwörter der Autor:innen

CAR T cellcheckpoint inhibitorsglioblastomaimmunotherapyvaccines

Autor:innen und Institutionen

  • Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
  • Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France.
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
  • Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.
  • Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy.

ORCID-Profile: Ahmed Idbaih, Giuseppe Lombardi

Zitieren

APA

Maccari, M., Baek, C., Caccese, M., Mandruzzato, S., Fiorentino, A., Internò, V., Bosio, A., Cerretti, G., Padovan, M., Idbaih, A., & Lombardi, G. (2024). Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities. The Oncologist. https://doi.org/10.1093/oncolo/oyad321

Vancouver

Maccari M, Baek C, Caccese M, Mandruzzato S, Fiorentino A, Internò V, et al. Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities. The Oncologist. 2024. doi:10.1093/oncolo/oyad321

BibTeX
@article{Maccari2024,
  author = {Maccari, Marta and Baek, Chooyoung and Caccese, Mario and Mandruzzato, Susanna and Fiorentino, Alba and Internò, Valeria and Bosio, Alberto and Cerretti, Giulia and Padovan, Marta and Idbaih, Ahmed and Lombardi, Giuseppe},
  title = {Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities},
  journal = {The Oncologist},
  year = {2024},
  doi = {10.1093/oncolo/oyad321}
}
Kostenlos starten →